Myopia (Nearsightedness) Progression Prevention Support Protocol

Myopia (nearsightedness) occurs when the eye grows too long, causing distant objects to appear blurry while close objects remain clear. Myopia typically develops in childhood and progresses through the teenage years. The global prevalence of myopia is increasing dramatically - by 2050, half the world's population may be myopic. High myopia (>-6 diopters) significantly increases risk of serious eye conditions including retinal detachment, glaucoma, and myopic maculopathy.

CRITICAL: Myopia progression prevention is best achieved through evidence-based interventions managed by an eye care professional (optometrist or ophthalmologist). Proven interventions include: 1) Increased outdoor time (2+ hours daily) - the most important environmental factor; 2) Atropine eye drops (low-dose 0.01-0.05%); 3) Orthokeratology (overnight contact lenses); 4) Peripheral defocus contact lenses. These supplements may support general eye health but are NOT proven to prevent myopia progression. The relationship between vitamin D and myopia may reflect outdoor time rather than vitamin D itself.

* Vitamin D levels are associated with myopia risk in many studies. However, this relationship likely reflects outdoor light exposure rather than a direct vitamin D effect. Outdoor time (with its bright light and distant focusing) is the key protective factor. Still, maintaining adequate vitamin D supports overall eye health.

* Omega-3 Fatty Acids support retinal development and function.

* Lutein and Zeaxanthin are macular carotenoids that protect the retina from light damage.

* Zinc is essential for retinal function and vitamin A metabolism.

* Vitamin A is essential for visual function.

* Bilberry supports ocular blood flow.

* Vitamin C supports collagen in eye structures.

Expected timeline: These supplements support general eye health over the long term. For myopia progression prevention in children, the primary intervention is increased outdoor time combined with clinical interventions (atropine, ortho-K, or special contact lenses) as recommended by an eye care professional.

Clinical Perspective

Myopia: refractive error from excessive axial elongation of the eye. Prevalence: epidemic - 80-90% in East Asian adolescents; increasing globally. High myopia (>-6D or axial length >26mm): risk of pathologic complications (myopic maculopathy, retinal detachment, glaucoma, cataract). Risk factors: genetics (parental myopia), near work, limited outdoor time, education/urbanization.

CRITICAL: Evidence-based myopia control interventions: 1) Outdoor time - 2+ hours/day; strongest environmental protective factor; likely bright light and peripheral defocus mechanism. 2) Low-dose atropine (0.01-0.05%) - slows progression ~50%; minimal side effects at low doses. 3) Orthokeratology - overnight corneal reshaping lenses; ~50% reduction in progression. 4) Peripheral defocus contact lenses (MiSight, Acuvue Abiliti) - FDA approved for myopia control in children. 5) Special spectacle lenses (DIMS, HAL) - emerging evidence. Supplements NOT proven for myopia control - outdoor time is the behavioral intervention. Vitamin D association may be marker of outdoor exposure.

* Vitamin D (B-grade): Association with myopia; possibly outdoor time marker. Systematic review: myopia (PMID: 28188100). Meta-analysis: serum levels (PMID: 26619232). 1000-4000 IU daily.

* Omega-3 Fatty Acids (C-grade): Retinal development. Review: eye development (PMID: 27003320). 500mg-2g daily.

* Lutein (C-grade): Macular protection. Systematic review: eye health (PMID: 25972525). 10mg daily.

* Zeaxanthin (C-grade): Works with lutein. Systematic review: eye health (PMID: 25972525). 2mg daily.

* Zinc (C-grade): Retinal function; vitamin A transport. Review: eye health (PMID: 23574640). 10-25mg daily.

* Vitamin A (C-grade): Visual function. Review: (PMID: 22555058). 2500-5000 IU daily.

* Bilberry (C-grade): Anthocyanins; circulation. Review: eye health (PMID: 25109868). 80-160mg extract daily.

* Vitamin C (D-grade): Antioxidant; collagen. Review: eye health (PMID: 16155475). 250-500mg daily.

Assessment targets: Cycloplegic refraction (accurate myopia measurement), axial length (progression marker), fundus examination (pathologic changes).

Protocol notes: Outdoor time: most evidence-based behavioral intervention; bright light exposure (1000+ lux) and looking at distant objects; 2 hours daily significantly protective; works even with near work. Near work: 20-20-20 rule (every 20 minutes, look 20 feet away for 20 seconds). Screen time: association with myopia partly confounded by replacing outdoor time. Atropine: start 0.01%, increase if progression continues; minimal pupil dilation/accommodation effects at low dose. Ortho-K: overnight wear; effective but requires compliance; infection risk if poor hygiene. MiSight/Acuvue Abiliti: daytime soft contacts; FDA approved 8-12 years. Reading posture: maintain 30-40cm distance. Lighting: adequate light for reading. High myopia monitoring: fundus photos, OCT for myopic changes; annual exams. Genetic: GWAS identified many variants; parental myopia strongest risk factor. East Asian populations: highest rates; likely gene-environment interaction. Prevention window: most important during childhood/adolescence when eye is growing. Pathologic myopia: may need retina specialist for complications. Supplements: general eye health support; not proven for myopia control.

View All Protocols